NOVARTIS PHARMACEUTICALS CORPORATION: public contracts won without a rival in United States: 60 uncontested awards; 98% of its awards; 6 without a competition; 54 single bid.
Assay record ASY-US-0ZDMENL1SD · Cite as: Assay Systems, “NOVARTIS PHARMACEUTICALS CORPORATION: public contracts won without a rival in United States”, https://assay-systems.com/register/us/uncontested/s/novartis-pharmaceuticals-corporation/
NOVARTIS PHARMACEUTICALS CORPORATION won 60 of its 61 public contract awards in United States without a rival from 2025-02-05 to 2026-09-30, worth $47.3M: 6 without a competition and 54 after a competition that drew a single bid. 5 buyers awarded it without a rival, the largest Department of Veterans Affairs with 50.
An award is uncontested when the buyer had no rival offer to weigh: it was made without a competition (direct award, negotiated procedure without a call for tenders, sole-source or advance-notice contract), or a competition was held and only one bid arrived. Every count below is built award by award from the official notices. Awards to individuals are not included.
Department of Veterans Affairs gave NOVARTIS PHARMACEUTICALS CORPORATION 51 awards: 0 without a competition, 50 after a competition with a single bid. First 2025-02-05, latest 2026-09-30.
Defense Health Agency gave NOVARTIS PHARMACEUTICALS CORPORATION 5 awards: 4 without a competition, 1 after a competition with a single bid. First 2025-09-08, latest 2026-06-18.
Department of the Army gave NOVARTIS PHARMACEUTICALS CORPORATION 2 awards: 2 without a competition, 0 after a competition with a single bid. First 2025-08-18, latest 2026-06-30.
Federal Prison System / Bureau of Prisons gave NOVARTIS PHARMACEUTICALS CORPORATION 2 awards: 0 without a competition, 2 after a competition with a single bid. First 2026-06-17, latest 2026-06-17.
Office of Assistant Secretary for Preparedness and Response gave NOVARTIS PHARMACEUTICALS CORPORATION 1 award: 0 without a competition, 1 after a competition with a single bid. First 2026-07-08, latest 2026-07-08.
| Date | Buyer | How | Value | Stated reason |
|---|---|---|---|---|
| 2026-09-30 | Department of Veterans Affairs 36C24126F0136 | Single bid FULL AND OPEN COMPETITION | $2.5M | — |
| 2026-08-24 | Department of Veterans Affairs 36C25526N0394 | Single bid FULL AND OPEN COMPETITION | $892K | — |
| 2026-07-17 | Department of Veterans Affairs 36C26226F0314 | Single bid FULL AND OPEN COMPETITION | $823K | — |
| 2026-07-13 | Department of Veterans Affairs 36C24526N0724 | Single bid FULL AND OPEN COMPETITION | $34.9K | — |
| 2026-07-08 | Office of Assistant Secretary for Preparedness and Response HHSO100201700026C | Single bid FULL AND OPEN COMPETITION | $-2,539,496 | — |
| 2026-06-30 | Department of the Army W81K0026FA128 | No competition NOT COMPETED | — | ONLY ONE SOURCE-OTHER (FAR 6.302-1 OTHER) |
Every uncontested award in United States · All countries · NOVARTIS PHARMACEUTICALS CORPORATION in the register
Source: USAspending.gov prime award transactions (contracts). Awards are matched to their buyer and supplier as published. Updated 17 October 2026.